5-års totaloverlevelse for plateepitelkarsinom

Basert på FIGO stadium (Beller et al., 2006; FIGO (International Federation of Gynecology and Obstetrics) 26th Annual Report on the Results of Treatment in Gynecological Cancer, 2006)

Stadium I : 90 % (Ia 98 %, Ib 88 %)

Stadium II: 81 %

Stadium III: 68 %

Stadium IV: 20 %

Residiv: 25–35 %

5-års overlevelse for ikke-plateepitel vulvacancer

• Bartholini cancer 64,5 % (Beller et al., 2006; FIGO (International Federation of Gynecology and Obstetrics) 26th Annual Report on the Results of Treatment in Gynecological Cancer, 2006)
• Melanom 61,9 %
• Adenokarsinom 32,5 %